JOURNAL OF BUON, vol.12, no.2, pp.203-208, 2007 (Journal Indexed in SCI)
Article / Article
Title of Journal :
JOURNAL OF BUON
concomitant chemoradiotherapy, oral fluoropyrimidine, rectal cancer, survival, toxicity, UFT, ORAL LEUCOVORIN, PHASE-III, FLUOROURACIL, CHEMOTHERAPY, THERAPY, UFT, MULTICENTER, TRIAL
Purpose: We report the feasibility and toxicity profile, and the impact on local control, disease-free survival and overall survival rates of our study which consisted of postoperative concurrent chemoradiotherapy, followed by adjuvant chemotherapy using uracil-tegafur (UFT)/leukovorin (L V) in locally advanced rectal cancer patients.